Patent details

EP2079446 Title: PALIPERIDONE SUSTAINED RELEASE FORMULATION

Basic Information

Publication number:
EP2079446
PCT Application Number:
PCT/US/2008/010014
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087955415
PCT Publication Number:
WO/2009/025859
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PALIPERIDONE SUSTAINED RELEASE FORMULATION
French Title of Invention:
FORMULATION À LIBÉRATION PROLONGÉE DE PALIPÉRIDONE
German Title of Invention:
PALIPERIDONFORMULIERUNG MIT VERZÖGERTER FREISETZUNG
SPC Number:

Dates

Filing date:
21/08/2008
Grant date:
26/10/2011
EP Publication Date:
26/10/2011
PCT Publication Date:
26/02/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/07/2009
EP B1 Publication Date:
26/10/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/08/2012
Expiration date:
21/08/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/08/2008
 
 

Name:
Teva Pharmaceutical Industries Ltd.
Address:
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva, Israel (IL)

Inventor

1

Name:
DI CAPUA Simona
Address:
Israel (IL)

2

Name:
FOX Michael
Address:
Israel (IL)

3

Name:
REINBERG Ronny
Address:
Israel (IL)

Priority

Priority Number:
935597 P
Priority Date:
21/08/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/16;
Filing date Document type Number of pages